Sunny R K Singh, MD
Medical Oncology · North Little Rock, ARNPI 1336522895
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $695 of the $784 with a category attached, or 88.7%. 8 manufacturers reported payments, led by Endologix LLC at 37.0% of the total. Reporting peaked in 2019 at $339 and has fallen 77.4% since, to $77 in 2025. That places this record below the midpoint for medical oncology clinicians in AR, where the typical reported total is $1,872.
Across 11 payments — averaging $71.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$290
- Genentech USA, Inc.$214
- Bayer$125
- Medtronic$55
- AbbVie$35
- Sobi, Inc$28
- plus $37 from 2 others
What the payments were for
- Food & beverage$69589%
- Education$8911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 2 | $290 |
| Genentech USA, Inc. | 2 | $214 |
| Bayer | 1 | $125 |
| Medtronic | 1 | $55 |
| AbbVie(2 entities) | 2 | $35 |
| Sobi, Inc | 1 | $28 |
| Abiomed | 1 | $26 |
| Emmaus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$290
- Xofigo$125
- Herceptin$125
- Perjeta$125
- Kadcyla$125
How this compares
$784 in reported general payments places this provider in the 40th percentile of 20 medical oncology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BraftoviEncorafenib | 12 | $201,034 |
| MektoviBinimetinib | 12 | $141,912 |
| OxycontinOxycodone Hcl | 25 | $14,796 |
| EliquisApixaban | 17 | $9,780 |
| Abiraterone Acetate | 12 | $2,632 |
| Oxycodone Hcl | 127 | $1,477 |
| Hydroxyurea | 44 | $1,305 |
| Dexamethasone | 41 | $634 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $571 |
| Prochlorperazine Maleate | 17 | $444 |
| Acyclovir | 32 | $411 |
| Ondansetron Hcl | 31 | $391 |
| Potassium Chloride | 15 | $343 |
| Methadone Hcl | 19 | $245 |
| Hydromorphone Hcl | 16 | $133 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in North Little Rock
- Shadiqul HoqueNorth Little Rock$1K
- Anusha JillellaNorth Little Rock$584
- Muthu KumaranLittle Rock$193K
- Sunilkumar KakadiaHot Springs$31K
- Cesar Gentille SanchezLittle Rock$29K
- Stephen ToothakerSearcy$19K
- Ryan KochSearcy$15K
- Zaki SammanFort Smith$9K
- Kristen SagerMena$8K
- Chen HuangHarrison$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.